bpc 157 safety evidence clinical trials I've worked with patients using BPC-157 as part of comprehensive recovery protocols for tendon injuries, joint discomfort, overuse injuries, exercise recovery, and gastrointestinal support. While the published research is still primarily preclinical bpc-157 human clinical trials evidence
Description
Compounds: BPC-157 at 250 micrograms twice daily, subcutaneous near the injury site

GEMINI 1 and 2 phase III trials showed that tolebrutinib was not superior to teriflunomide in reducing relapses, but there was a reduction in 6-month confirmed disability progression, although this was not formally tested (80)

the two or three components mentioned above are made to occur in an ampule or vial by dissolving or suspending them in sterile water or sterile physiological saline

PMID: 48 WangYNZhangZHLiuHJGuoZYZouLZhangYMet al

In the United States, between 3 to 6 % of the population are vitamin B12 deficient and up to 20% have marginally depleted levels (3)
